Alexandre R. Zlotta

Also affiliated with University Health Network, University of Toronto, Princess Margaret Cancer Centre, Collaborative Group (United States), Sinai Health System

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse”.

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse

Nature Communications(2021)10.1038/s41467-021-26489-0

N/A

0.867DataRank · unranked

27 citations

Julie Livingstone, Jeffrey L. Wrana, Antonio Finelli, Housheng Hansen He, Theodorus Van der Kwast +4 more

Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening

European Urology(2020)10.1016/j.eururo.2020.06.026

N/A

0DataRank · unranked

4 citations

Sigrid Carlsson, Antonio Finelli, Neil Fleshner, Alexandre R. Zlotta